Lisha Ye
Xueyuan Road #270
Wenzhou, China
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A Prompt-Preserving SAM ViT-B Adaptation Framework with Historical Branch Fusion and Soft Convolutional Expert Weighting for Medical Image Segmentation.
Journal: Bioengineering (Basel, Switzerland)
Published: June 25, 2026
Timing of immune checkpoint inhibitor infusion predicts survival in advanced esophageal squamous cell carcinoma: A retrospective cohort study.
Journal: Therapeutic advances in medical oncology
Published: March 20, 2026
The tumor-microenvironment-associated prognostic gene TIGIT promotes malignant phenotypes in esophageal carcinoma.
Journal: Translational oncology
Published: February 20, 2026
Retrospective analysis of the optimal timing of immunotherapy in patients with advanced esophageal squamous cell carcinoma: a window of opportunity.
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: November 30, 2025
c-MET expression and immune landscape in locally advanced patients with non-small cell lung cancer undergoing radiochemotherapy and consolidative immunotherapy.
Journal: Translational lung cancer research
Published: September 08, 2025
Enhanced efficacy of lung cancer treatment with radiotherapy and immune checkpoint inhibitors without increased pneumonia risk: a systematic review and meta-analysis of randomized controlled trials.
Journal: Frontiers in immunology
Published: August 14, 2025
Osimertinib Plus Antiangiogenic Agents: A Promising New Paradigm With Uncertain Results.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 24, 2025
Concerns Regarding Sample Size and Credibility of Progression-Free Survival Results.
Journal: JAMA oncology
Published: November 14, 2024
[18F]FDG-PET-guided radiotherapy for stage III non-small-cell lung cancer.
Journal: The Lancet. Oncology
Published: September 01, 2024
Targeting the MET gene: unveiling therapeutic opportunities in immunotherapy within the tumor immune microenvironment of non-small cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: July 13, 2024
D-dimer levels predict the treatment efficacy and prognosis of esophageal squamous cell carcinoma treated with PD-1/PD-L1 inhibitors.
Journal: The International journal of biological markers
Published: June 18, 2024
A narrative review on advances in neoadjuvant immunotherapy for esophageal cancer: Molecular biomarkers and future directions.
Journal: International journal of cancer
Published: June 11, 2024
Last Updated: 09/26/2026